Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cord Blood Transplantation in Children and Young Adults With Hematologic Malignancies and Non-malignant Disorders
NCT04644016Phase 2Recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Nov 2020
- Primary completion
- Dec 2026
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial in hematologic malignancy and hematologic disorder (2 arms), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Treatment related mortality at 1 year. Started Nov 2020; status: recruiting.
02
Conditions
hematologic malignancyhematologic disorder
Beyond the preview
Go deeper on NCT04644016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04644016.